MT1P3 and type 2 diabetes mellitus: In this context, the non-coding Metallothionein 1 Pseudogene 3 (MT1P3) was found to be significantly upregulated in MKs from type 2 diabetes patients compared to healthy controls and, most importantly, had an impact on platelet activation and expression of the P2Y12 by sponging miR-126.